Wikidata

(Q38564225)

English

Statistical Considerations in Clinical Trial Design of Immunotherapeutic Cancer Agents

scientific article published on September 2015

In more languages

Statements

title
Statistical Considerations in Clinical Trial Design of Immunotherapeutic Cancer Agents (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
26261889
retrieved
4 September 2017
author name string
Roger B Cohen
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
26261889
retrieved
4 September 2017
Gary Acton
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
26261889
retrieved
4 September 2017
Llew Keltner
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
26261889
retrieved
4 September 2017
Melissa Price
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed ID
26261889
retrieved
4 September 2017
Eckhard R Podack
series ordinal
7
1 reference
stated in
Europe PubMed Central
PubMed ID
26261889
retrieved
4 September 2017
Taylor H Schreiber
series ordinal
8
1 reference
stated in
Europe PubMed Central
PubMed ID
26261889
retrieved
4 September 2017
publication date
1 September 2015
1 reference
stated in
Europe PubMed Central
PubMed ID
26261889
retrieved
4 September 2017
page(s)
259-266
1 reference
stated in
Europe PubMed Central
PubMed ID
26261889
retrieved
4 September 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q38564225&oldid=1767366832"